FDA 'Remains Concerned' Certain Birth-Control Pills Have Clot Risk 29290

The Food and Drug Administration issued a statement Monday saying in an ongoing review of a number of studies, it has not yet reached a conclusion about the blood clot risk in certain brands of birth-control pills, but the agency "remains concerned" that the risk is too high.  The FDA is tracking a number of  birth-control pill brands that contain drospirenone, a form of the synthetic hormone progestin.  The brands include Yaz (generics Gianvi and Loryna), Yasmin (generics Ocella, Syeda, and Zarah), Beyaz, and Safyral